Search

everythinglearnresearchcommunity

for

Search:↓

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Biliverdin IXβ and IXδ help Pseudomonas aeruginosa adapt to chronic infections.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Blood cells turned into stem cells can become skin cells similar to normal ones, potentially helping in skin therapies.

CRISPR-Cas9 allows precise DNA editing but raises ethical concerns about modifying human embryos.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Targeting endolysosomes may help treat COVID-19.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Biodegradable polysaccharide gels can improve skin healing and reduce scarring.

Elderly people, especially with chronic conditions, are more at risk of severe COVID-19 complications and need preventive care and social support.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

HPV type 56 can hide in hair follicles even without visible warts.

Scalp hair folliculitis is hard to diagnose and treat due to various causes and complex classification.

COVID-19 may harm male fertility and damage the reproductive system.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

Global collaboration in dermatology improved data sharing and patient care during COVID-19.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Timely and coordinated efforts are crucial in managing a public health crisis like COVID-19.